These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10987582)

  • 1. Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature.
    Blumenthal RS; Cohn G; Schulman SP
    J Am Coll Cardiol; 2000 Sep; 36(3):668-73. PubMed ID: 10987582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention versus medical therapy for coronary heart disease.
    Maron DJ
    Curr Atheroscler Rep; 2000 Jul; 2(4):290-6. PubMed ID: 11122756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
    Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
    N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical therapy versus revascularization: the atorvastatin versus revascularization treatment AVERT trial.
    Waters DD
    Can J Cardiol; 2000 Jan; 16 Suppl A():11A-3A. PubMed ID: 10653925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with Atorvastatin Versus Revascularization Treatments (AVERT).
    McCormick LS; Black DM; Waters D; Brown WV; Pitt B
    Am J Cardiol; 1997 Nov; 80(9):1130-3. PubMed ID: 9359537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Cohen DJ; Carrozza JP; Baim DS
    N Engl J Med; 1999 Dec; 341(24):1853-4; author reply 1854-5. PubMed ID: 10610464
    [No Abstract]   [Full Text] [Related]  

  • 7. Atorvastatin versus revascularization treatment (AVERT): fact or fancy?
    Singh BM; Puri S; Saucedo J; Talley JD
    Am Heart J; 2000 Jul; 140(1):6-9. PubMed ID: 10874254
    [No Abstract]   [Full Text] [Related]  

  • 8. [AVERT [The Atorvastatin versus Revascularization Treatment]].
    Mokuno H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():436-41. PubMed ID: 11347110
    [No Abstract]   [Full Text] [Related]  

  • 9. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Ricciardi MJ; Davidson CJ
    N Engl J Med; 1999 Dec; 341(24):1854; author reply 1854-5. PubMed ID: 10610465
    [No Abstract]   [Full Text] [Related]  

  • 10. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Bloom JM
    N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
    [No Abstract]   [Full Text] [Related]  

  • 11. Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial.
    Waters D
    Eur Heart J; 2000 Jul; 21(13):1029-31. PubMed ID: 10843815
    [No Abstract]   [Full Text] [Related]  

  • 12. Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.
    Songco AV; Brener SJ
    Curr Cardiol Rep; 2012 Aug; 14(4):397-407. PubMed ID: 22555943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical data: AVERT and QUO VADIS.
    O'Neill BJ
    Can J Cardiol; 2000 Aug; 16 Suppl E():32E-35E. PubMed ID: 10906624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial.
    Mikhaildis DP; Wierzbicki AS; Reynolds TM
    Eur Heart J; 2001 Jun; 22(11):972-3. PubMed ID: 11428822
    [No Abstract]   [Full Text] [Related]  

  • 15. Results from late-breaking clinical trials sessions at ACCIS '99 and ACC '99. American College of Cardiology.
    Morris DC
    J Am Coll Cardiol; 1999 Jul; 34(1):1-8. PubMed ID: 10399983
    [No Abstract]   [Full Text] [Related]  

  • 16. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
    Gómez-Gerique JA; Casciano R; Stern L; Rejas J
    Eur J Health Econ; 2004 Oct; 5(3):278-84. PubMed ID: 15714350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of the month. REVERAL and PROVE-IT: confirmation of the concept " the lower, the better" for cholesterol therapy in patients with coronary heart disease].
    Scheen AJ; Kulbertus H
    Rev Med Liege; 2004 Mar; 59(3):167-73. PubMed ID: 15139406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD; Schwenkglenks M; Rutishauser W
    Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant therapy for coronary artery disease: don't paint the walls without treating the termites!
    Ewy GA
    Arch Intern Med; 1999 Jun; 159(12):1279-80. PubMed ID: 10386503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.